Your browser doesn't support javascript.
loading
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
Sun, Liangzhan; Xi, Shaoyan; Zhou, Zhengdong; Zhang, Feifei; Hu, Pengchao; Cui, Yuzhu; Wu, Shasha; Wang, Ying; Wu, Shayi; Wang, Yanchen; Du, Yuyang; Zheng, Jingyi; Yang, Hui; Chen, Miao; Yan, Qian; Yu, Dandan; Shi, Chaoran; Zhang, Yu; Xie, Dan; Guan, Xin-Yuan; Li, Yan.
  • Sun L; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Xi S; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Zhou Z; State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.
  • Zhang F; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu P; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cui Y; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Wu S; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Wang Y; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Wu S; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Wang Y; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Du Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zheng J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang H; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Chen M; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Yan Q; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Yu D; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Shi C; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Zhang Y; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Xie D; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Guan XY; State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.
  • Li Y; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Oncogene ; 41(5): 732-744, 2022 01.
Article en En | MEDLINE | ID: mdl-34845378
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article